The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Issue of Shares, Warrants and Total Voting Rights

15 Aug 2019 09:20

RNS Number : 1753J
mporium Group PLC
15 August 2019
 

Mporium Group plc

("Mporium", the "Company" or the "Group")

 

Issue of Shares and Warrants and Total Voting Rights

 

Mporium Group plc (AIM:MPM), the technology firm delivering event-driven marketing, announces that on 14 August 2019, the Company issued and allotted 6,625,000 ordinary shares of 0.5 pence each in the Company ("Ordinary Shares") to Novum Securities Limited ("Novum") in lieu of fees.

Application has been made for the 6,625,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 20 August 2019 ("Admission"). The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 1,044,107,052 with no Ordinary Shares held in treasury. Accordingly, the figure of 1,044,107,052 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

In addition, the Company has issued warrants over 15,000,000 Ordinary Shares (the "Warrants") to Ridgeway Capital LLP in consideration for their business restructuring services. The Warrants are exercisable at any time between 10 December 2019 and 10 December 2021 and have an exercise price of 1.5 pence per share.

 

Enquiries

 

Mporium:

020 3841 8411

Tom Smith, Chief Executive Officer

 

 

 

finnCap (NOMAD / joint broker)

020 7220 0500

Henrik Persson / Kate Bannatyne (Corporate Finance)

Andrew Burdis (Corporate Broking)

 

 

Novum Securities Limited (joint broker)

020 7399 9427

Colin Rowbury (Corporate Broking)

 

Yellow Jersey PR:

020 3004 9512

Tim Thompson / Annabel Atkins / Felicity Winkles

 

 

 

 

Notes to editors

About Mporium

Mporium is a technology company delivering event-driven digital marketing. Mporium's proprietary technology enables advertisers, to identify and leverage moments when there are significant changes in the levels of consumer engagement. MporiumX is the performance-led moment marketing media trading division of Mporium Group.

 

Based in the UK, Mporium Group plc is quoted on AIM, the junior market of the London Stock Exchange plc.

www.mporium.com

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRGIGDIRBBBGCU

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.